TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > SMARTPHLEX > SMARTCHECK MDR

SMARTMDRSMARTCHECK MDR

Regulation (EU) 2017/745 (MDR) on medical devices became effective on May 26, 2021

SMARTCHECK MDR is a highly effective tool that PharmaLex developed to assist medical device manufacturers in assessing the MDR readiness of their medical devices and quality management systems. It was developed based on our deep understanding of both the greater complexities companies now face under the MDR and the many different types of products affected by the new requirements — from traditional devices to new technologies, to software-as-a-medical-device solutions such as mobile phone apps. Let PharmaLex’ SMARTCHECK MDR tool handle these new and complex compliance needs on your behalf so that you can be assured your devices will get to — and stay on — the European market.

SMARTCHECK MDR is a unique tool that helps our clients learn their compliance status and the steps necessary to ensure full compliance. It does so by providing evidence both efficiently and cost effectively — for example, by offering insights into MDR readiness — and it frees you to focus on your business and on developing your medical device while we attend to full regulatory review. All you need to do is answer the questions, and the tool will provide a roadmap of the required steps.

One of our team of experienced medical device consultants will be available to answer questions during the implementation of SMARTCHECK MDR. Once implemented, a half-day workshop will be held to discuss the findings and identify the most appropriate way forward to work towards full MDR compliance from both a regulatory and quality viewpoint. The outcomes from the workshop will be documented in a comprehensive report to support you through the launch and maintenance of your devices on the European market.

ARE YOU MDR READY

Take our survey consisting of five simple questions.  Your answers will give you a taste of the ways our SMARTCHECK MDR tool will help you transition – and continue commercializing – your products.  The results are delivered in an easy-to-view traffic light alongside a clear explanation.

TAKE SURVEY HERE

DIGITAL HEALTH ASSESSMENT

Are you developing health-related software or smart apps? Do you know if your software or app will be classified as a medical device? Does your product meet the MDR requirements? Complete our short questionnaire
to find out what help you need.

QUESTIONNAIRE

Contact us to find out how PharmaLex can support your EUMDR readiness

CONTACT US

Features

  • Compliance: The SMARTCHECK MDR tool will complete a full MDR-readiness assessment of your product(s).
  • Quick access to expertise: Concise, focused, and highly effective results will ensue after a half-day workshop at fixed cost.
  • Objective assessment: The tool will give full transparency on where you stand and clarity on what steps to take next.
  • Reporting: A comprehensive report will document everything you must do to achieve MDR compliance.

Benefits

  • A unique, evidence-based, efficient, and cost-effective way to find out where you stand and what to do next.
  • An effective litmus test and smartly chosen targeted measures to implement.
  • A SMARTCHECK MDR-conducted assessment that lets you focus on your business and future product development.
  • Peace of mind via a 360-degree assessment of risk in achieving compliance.

Find out more about our depth of expertise by watching a video in which PharmaLex medical device specialists Malcolm Pinfold and Kim Wharton discuss the key considerations and implications of the new medical device regulation and the things companies should attend to:

Related News

Medical device software brings new complications around compliance
Medical device software brings new complications around compliance
30th May 2022
Navigating the impact of the IVDR on marketed products
Navigating the impact of the IVDR on marketed products
24th March 2022
Next Steps for EUDAMED implementation within MDR
Next Steps for EUDAMED implementation within MDR
7th March 2022

Related Resources

Fact Flyers

  • Medical Device Regulations Transition Support
  • Medical Devices for the Pharmaceutical Industry
  • Medical Device Services

Case Studies

  • PharmaLex keeps medical device CE marking on track

White Papers

  • QMS aspects of the Medical Device Regulation
  • The medical device regulations and their implications on device vigilance
  • In Vitro Diagnostic Medical Devices Regulation – Summary of changes and impact for manufacturers
  • Medical Device Software and Mobile Apps
  • Navigating the regulatory submission process for a class III medical device with ancillary medicine
  • The Medical Device Regulation – Readiness for May 2021
  • Software, AI and Medical Devices - What's Up?

Webinars

  • Get Your Design in Control
  • Medical Device Risk Management for Patient and Product Safety
  • An Update to In Vitro Diagnostics Regulatory Requirements Worldwide
  • Medical Device Software: Current Developments in the Regulatory World
  • Medical Device Clinical Evaluation Reports (CERs) -What you need to know

Infographics

  • Medical Device Regulations

Related Services

  • GxP Services
  • Health Authority / Agency Interaction
  • MedTech Services
  • PAI Readiness
  • Quality Management Systems
  • Tech Transfer / Scale-up
  • Toxicology Services
  • Virtual Audits
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
PharmaLexGLOBALPharmaLex@PharmaLexGLOBAL·
24 Jun

Milena Shuytsova-Mircheva and Lisa Pascoe latest blog here https://www.pharmalex.com/sponsors-gear-up-for-a-smoother-process-with-ctis-but-must-first-overcome-key-hurdles/ discusses the benefit of the Clinical Trial Information System (CTIS).

💡 Interested in CTIS? Take the Phlexglobal survey to evaluate your preparation https://www.phlexglobal.com/ctis-survey

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • There was a close relationship between the regulatory strategy and the writing activities. You developed a fine-tuned regulatory strategy which will be a key factor to smooth the approval of our dossier.

    Large Pharma, Global
    VP Regulatory Strategy
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team



    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    Click here to view our Privacy Policy.



      .
      You can unsubscribe at any time at
      data.protection@pharmalex.com

      Click here to view our Privacy Policy.



        .
        You can unsubscribe at any time at
        data.protection@pharmalex.com

        Click here to view our Privacy Policy.

          Please DO NOT send us event/conference information.
          We will not respond and these will be deleted immediately.





          Select your state:

          .
          You can unsubscribe at any time at
          data.protection@pharmalex.com

          Click here to view our Privacy Policy.

            Please DO NOT send us event/conference information.
            We will not respond and these will be deleted immediately.






            Select your state:

            Privacy Policy

            .
            If you do not wish to receive any communication from us, you may unsubscribe at any time.

            #AskTheExpert #TogetherBEYONDCOVID19





              Select your state:

              .
              You can unsubscribe at any time at data.protection@pharmalex.com

              If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

              #TogetherBEYONDCOVID19

              We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for